Literature DB >> 21038163

Cognitive and motor control in neurofibromatosis type I: influence of maturation and hyperactivity-inattention.

Stephan Huijbregts1, Hanna Swaab, Leo de Sonneville.   

Abstract

Thirty children and adolescents with Neurofibromatosis Type 1 (NF1) and thirty controls performed neuropsychological tasks with varying cognitive control demands. Group differences, indicating poorer performance of individuals with NF1, increased as a function of cognitive control demands. Group by age interactions indicated greater differences among younger participants with respect to inhibitory control and motor function. When more cognitive control was required, particularly in working memory tasks, group differences were present across different ages. Excluding children with an attention deficit hyperactivity disorder (ADHD) diagnosis, which is highly prevalent among individuals with NF1, and further statistical control for hyperactivity-inattention, also reduced group differences regarding motor function and inhibition, but a cognitive control deficit remained evident for children and adolescents with NF1.

Entities:  

Mesh:

Year:  2010        PMID: 21038163     DOI: 10.1080/87565641.2010.508670

Source DB:  PubMed          Journal:  Dev Neuropsychol        ISSN: 1532-6942            Impact factor:   2.253


  16 in total

1.  Executive functioning profiles from the BRIEF across pediatric medical disorders: Age and diagnosis factors.

Authors:  Lauren S Krivitzky; Karin S Walsh; Evelyn L Fisher; Madison M Berl
Journal:  Child Neuropsychol       Date:  2015-07-06       Impact factor: 2.500

2.  Abnormal relationship between GABA, neurophysiology and impulsive behavior in neurofibromatosis type 1.

Authors:  Maria J Ribeiro; Inês R Violante; Inês Bernardino; Richard A E Edden; Miguel Castelo-Branco
Journal:  Cortex       Date:  2014-11-11       Impact factor: 4.027

3.  Social-emotional functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: relationships with cognitive, disease, and environmental variables.

Authors:  Staci Martin; Pamela Wolters; Andrea Baldwin; Andrea Gillespie; Eva Dombi; Katherine Walker; Brigitte Widemann
Journal:  J Pediatr Psychol       Date:  2012-02-21

Review 4.  A systematic review and meta-analysis of intellectual, neuropsychological, and psychoeducational functioning in neurofibromatosis type 1.

Authors:  Andrew J D Crow; Jennica M Janssen; Carolina Marshall; Anne Moffit; Laura Brennan; Christian G Kohler; David R Roalf; Paul J Moberg
Journal:  Am J Med Genet A       Date:  2022-05-12       Impact factor: 2.578

Review 5.  An executive functioning perspective in neurofibromatosis type 1: from ADHD and autism spectrum disorder to research domains.

Authors:  Taylor F Smith; Jessica A Kaczorowski; Maria T Acosta
Journal:  Childs Nerv Syst       Date:  2020-07-03       Impact factor: 1.475

6.  Abnormal brain activation in neurofibromatosis type 1: a link between visual processing and the default mode network.

Authors:  Inês R Violante; Maria J Ribeiro; Gil Cunha; Inês Bernardino; João V Duarte; Fabiana Ramos; Jorge Saraiva; Eduardo Silva; Miguel Castelo-Branco
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

7.  Does cognitive impairment explain behavioral and social problems of children with neurofibromatosis type 1?

Authors:  Stephan C J Huijbregts; Leo M J de Sonneville
Journal:  Behav Genet       Date:  2010-12-24       Impact factor: 2.805

Review 8.  Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

Authors:  Martha Milade Torres Nupan; Alberto Velez Van Meerbeke; Claudia Alejandra López Cabra; Paula Marcela Herrera Gomez
Journal:  Front Pediatr       Date:  2017-10-30       Impact factor: 3.418

9.  Boys with Oppositional Defiant Disorder/Conduct Disorder Show Impaired Adaptation During Stress: An Executive Functioning Study.

Authors:  Jantiene Schoorl; Sophie van Rijn; Minet de Wied; Stephanie van Goozen; Hanna Swaab
Journal:  Child Psychiatry Hum Dev       Date:  2018-04

10.  Long-term effects of cranial irradiation and intrathecal chemotherapy in treatment of childhood leukemia: a MEG study of power spectrum and correlated cognitive dysfunction.

Authors:  Marita Daams; Ilse Schuitema; Bob W van Dijk; Eline van Dulmen-den Broeder; Anjo Jp Veerman; Cor van den Bos; Leo Mj de Sonneville
Journal:  BMC Neurol       Date:  2012-08-28       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.